Annette Kleiser
Chief Executive Officer at Dalan Animal Health, Inc.
Profile
Annette Kleiser is the Chief Executive Officer & Director at Dalan Animal Health, Inc. She previously worked as a Senior Manager-Licensing at Amgen, Inc. and as Vice President-Business Development at Allon Therapeutics, Inc. from 2007 to 2008.
Dr. Kleiser holds a graduate degree from Universität Konstanz and a doctorate degree from Ludwig-Maximilians-Universität München.
Annette Kleiser active positions
| Companies | Position | Start |
|---|---|---|
Dalan Animal Health, Inc.
 Dalan Animal Health, Inc. BiotechnologyHealth Technology Dalan Animal Health, Inc. is a company that focuses on providing animal health solutions to support a more sustainable future. The company is based in Athens, GA, at the University of Georgia's innovation hub. The company uses a platform vaccine technology that allows the maternal animal to pass immune modulators to the next generation larvae before they hatch. The company plans to develop vaccines for other honeybee diseases and underserved industries, such as shrimp, mealworms, and insects used in agriculture. The CEO of the company is Annette Kleiser. | Chief Executive Officer | 30/11/2018 |
Former positions of Annette Kleiser
| Companies | Position | End |
|---|---|---|
| ALLON THERAPEUTICS INC. | Corporate Officer/Principal | 31/08/2008 |
| AMGEN INC. | Corporate Officer/Principal | - |
Training of Annette Kleiser
| Universität Konstanz | Graduate Degree |
| Ludwig-Maximilians-Universität München | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| ALLON THERAPEUTICS INC. | Health Technology |
| Private companies | 1 |
|---|---|
Dalan Animal Health, Inc.
Dalan Animal Health, Inc. BiotechnologyHealth Technology Dalan Animal Health, Inc. is a company that focuses on providing animal health solutions to support a more sustainable future. The company is based in Athens, GA, at the University of Georgia's innovation hub. The company uses a platform vaccine technology that allows the maternal animal to pass immune modulators to the next generation larvae before they hatch. The company plans to develop vaccines for other honeybee diseases and underserved industries, such as shrimp, mealworms, and insects used in agriculture. The CEO of the company is Annette Kleiser. | Health Technology |
- Stock Market
- Insiders
- Annette Kleiser
